Biomedical Technologies for Androgenic Alopecia Treatment: Advance, Mechanism and Future Direction

Area of Science:

• Biomedical Engineering
• Dermatology
• Regenerative Medicine

Background:

• Androgenetic alopecia (AGA) is the most prevalent form of hair loss, marked by progressive follicular miniaturization.
• Existing therapies for AGA have limitations in efficacy and safety, driving the need for novel approaches.

Purpose of the Study:

• To provide a comprehensive review of advanced biomedical technologies for treating androgenetic alopecia (AGA).
• To explore the potential of emerging technologies in overcoming challenges associated with AGA treatment.

Main Methods:

• Review of current literature on biomedical technologies applied to AGA.
• Analysis of novel pharmacological formulations, nanotechnology, stem cell therapies, and microneedle platforms.
• Examination of case studies focusing on pathogenic factors in AGA.

Main Results:

• Biomedical technologies offer advantages in penetrating skin barriers, enabling controlled drug release, and modulating the scalp's microenvironment.
• Emerging technologies like nanotechnology and stem cells show promise for improved AGA treatment efficacy.
• Current strategies leverage these technologies to address key pathogenic factors in AGA.

Conclusions:

• Advanced biomedical technologies represent a promising frontier for developing next-generation androgenetic alopecia therapies.
• Further research and development are needed to address challenges and optimize these innovative approaches for clinical application.